-
Detailed Analysis Generate Full Report Add to Watchlist
Values as of: 2024-07-30
Values as of: 2024-07-30
The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Banks Select Industry Index. The fund generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index tracks the performance of publicly traded national money centers and leading regional banks. It may invest in equity securities that are not included in the index, cash and cash equivalents or money market instruments, such as repurchase agreements and money market funds. The fund is non-diversified.
Company Website : www.spdrs.com
Currency: USD
Country : USA
Inception Date: 08/11/2005
Primary Benchmark: S&P Banks Select Industry TR USD
Primary Index: MSCI ACWI NR USD
Gross Expense Ratio: 0.35%
Management Expense Ratio: 0.35 %
N/A
N/A
| Symbol | Company Name | Allocation |
|---|---|---|
| CRXM | Taxus Cardium Pharmaceuticals Group Inc | 1.26 % |
N/A
N/A
| Symbol | Name | Mer | Price(Change) | Market Cap |
|---|---|---|---|---|
| XLF | Financial Select Sector SPDR®.. | 0.13 % |
N/A |
USD 45.92B |
| VFH | Vanguard Financials Index Fund.. | 0.10 % |
N/A |
USD 10.19B |
| FNCL | Fidelity® MSCI Financials Ind.. | 0.08 % |
N/A |
USD 1.78B |
| BIZD | VanEck BDC Income ETF | 0.41 % |
N/A |
USD 1.18B |
| FXO | First Trust Financials AlphaDE.. | 0.63 % |
N/A |
USD 0.91B |
| VPC | Virtus Private Credit ETF | 0.00 % |
N/A |
USD 0.05B |
| BDCZ | UBS AG London Branch ELKS 4 | 0.00 % |
N/A |
USD 0.03B |
| IXG | iShares Global Financials ETF | 0.46 % |
N/A |
N/A |
| IYF | iShares U.S. Financials ETF | 0.42 % |
N/A |
N/A |
| IAI | iShares U.S. Broker-Dealers & .. | 0.42 % |
N/A |
N/A |
| Symbol | Name | Weight | Mer | Price(Change) | Market Cap |
|---|---|---|---|---|---|
| INAV | 12.31 % | 0.00 % |
N/A |
N/A |
| Market Performance vs. Industry/Classification (Financial) | Market Performance vs. Exchange (NYSE Arca) | ||||||
| Value | Sector Median | Percentile Rank | Grade | Market Median | Percentile Rank | Grade | |
| YTD | |||||||
| Capital Gain | 17.64% | 76% | C+ | 84% | B | ||
| Dividend Return | 1.39% | 65% | D | 37% | F | ||
| Total Return | 19.04% | 76% | C+ | 84% | B | ||
| Trailing 12 Months | |||||||
| Capital Gain | 30.33% | 88% | B+ | 89% | A- | ||
| Dividend Return | 3.26% | 71% | C- | 49% | F | ||
| Total Return | 33.59% | 88% | B+ | 89% | A- | ||
| Trailing 5 Years | |||||||
| Capital Gain | 25.76% | 35% | F | 61% | D- | ||
| Dividend Return | 10.20% | 47% | F | 38% | F | ||
| Total Return | 35.96% | 24% | F | 58% | F | ||
| Average Annual (5 Year Horizon) | |||||||
| Capital Gain | 7.95% | 29% | F | 65% | D | ||
| Dividend Return | 9.89% | 18% | F | 63% | D | ||
| Total Return | 1.94% | 53% | F | 44% | F | ||
| Risk Return Profile | |||||||
| Volatility (Standard Deviation) | 35.42% | 24% | F | 27% | F | ||
| Risk Adjusted Return | 27.92% | 24% | F | 48% | F | ||
| Market Capitalization | 3.17B | N/A | N/A | N/A | N/A | ||
| Target Price Action | Rating Action | Analyst | Rating | Price | Date |
|---|
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
There is nothing we particularly like
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
